- Home
- EW
as 11-19-2025 11:17am EST
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
| Founded: | 1958 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 45.5B | IPO Year: | 2000 |
| Target Price: | $92.35 | AVG Volume (30 days): | 5.2M |
| Analyst Decision: | Buy | Number of Analysts: | 19 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.33 | EPS Growth: | -66.20 |
| 52 Week Low/High: | $65.94 - $87.20 | Next Earning Date: | 10-30-2025 |
| Revenue: | $5,883,800,000 | Revenue Growth: | 10.60% |
| Revenue Growth (this year): | 13.96% | Revenue Growth (next year): | 9.81% |
Stock Insider Trading Activity of Edwards Lifesciences Corporation (EW)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Ullem Scott B. | EW | CVP, Chief Financial Officer | Nov 10 '25 | Sell | $83.16 | 13,000 | $1,080,093.43 | 49,924 | |
| Lippis Daniel J. | EW | CVP, JAPAC | Nov 10 '25 | Sell | $82.55 | 1,020 | $84,196.00 | 22,001.91 | |
| Chopra Daveen | EW | CVP, TMTT | Aug 25 '25 | Sell | $81.95 | 2,500 | $204,865.00 | 30,996 |
Latest Edwards Lifesciences Corporation News
EW Breaking Stock News: Dive into EW Ticker-Specific Updates for Smart Investing
MT Newswires
6 days ago
Argus Research Adjusts Edwards Lifesciences Price Target to $105 From $90, Maintains Buy Rating
Simply Wall St.
6 days ago
Exploring 3 Undervalued Small Caps In Global With Insider Buying
Argus Research
7 days ago
Analyst Report: Edwards Lifesciences Corp
Argus Research
7 days ago
Market Update: EW, ABNB, SPOT
Barchart
8 days ago
Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish?
MT Newswires
8 days ago
Edwards Lifesciences Insider Sold Shares Worth $1,080,093, According to a Recent SEC Filing
Simply Wall St.
9 days ago
Edwards Lifesciences (EW): Exploring Valuation as Earnings Upgrades and Guidance Fuel Options Market Volatility
Business Wire
10 days ago
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
Compare EW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EW Edwards Lifesciences Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.